CordenPharma Increases US Peptide Manufacturing Capacity

CordenPharma expanded its solid-phase peptide manufacturing capacity at its CordenPharma Colorado GMP API facility in Boulder, CO. The expansion was made to accommodate a large spike in the demand for peptide APIs, and to continue an overall growth strategy, the company said in a July 7, 2020 pr